TrialArthritis & rheumatology (Hoboken, N.J.)2026

Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab.

Ellen Romich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.